SCHEMBL3578296

SCHEMBL3578296

NC(=O)c1ccc(C(=O)c2ccc3c(c2)NC(=O)C3=CNc2cccc(O)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAP3K7 O43318 2/20 0.45
TAB1 Q15750 2/20 0.45
PLK4 O00444 1/20 0.40
PLK1 P53350 1/20 0.40
PDPK1 O15530 3/20 0.38
RAF1 P04049 1/20 0.38
AKT2 P31751 2/20 0.38
BRAF P15056 1/20 0.38
PIM1 P11309 1/20 0.37
TLK2 Q86UE8 2/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
NFKB1 P19838 2/20 0.37
NFKB2 Q00653 2/20 0.37
KMT2A Q03164 2/20 0.37
RELA Q04206 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3575692 0.95 MAP3K7 (0.47) ALDH1A1CYP1A2CYP3A4MAP3K7TAB1
SCHEMBL3578300 0.93 ALDH1A1 (0.45) ALDH1A1CYP1A2CYP3A4MAP3K7TAB1
SCHEMBL3582226 0.93 PDPK1 (0.47) ALDH1A1CYP1A2CYP3A4MAP3K7TAB1
SCHEMBL3575699 0.90 MAP3K7 (0.46) ALDH1A1CYP1A2CYP3A4MAP3K7TAB1
SCHEMBL3582327 0.88 NTRK3 (0.47) ALDH1A1CYP1A2CYP3A4MAP3K7TAB1
SCHEMBL3582324 0.88 NTRK3 (0.47) ALDH1A1CYP1A2CYP3A4MAP3K7TAB1
SCHEMBL3584594 0.88 PDPK1 (0.48) ALDH1A1CYP1A2CYP3A4MAP3K7TAB1
SCHEMBL3580084 0.86 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP3A4MAP3K7TAB1
SCHEMBL3580088 0.86 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP3A4MAP3K7TAB1
SCHEMBL3582233 0.84 RAF1 (0.46) ALDH1A1CYP1A2CYP3A4MAP3K7TAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7692005-B2 Kinase inhibitors ALLERGAN, INC. (US) 2010-04-06 US claimed
EP-1902025-A1 KINASE INHIBITORS Allergan, Inc. (US) 2008-03-26 EP claimed
US-20070032478-A1 Kinase Inhibitors ALLERGAN, INC. 2007-02-08 US claimed
WO-2007008895-A1 KINASE INHIBITORS ALLERGAN, INC. (US) 2007-01-18 WO claimed
US-7749530-B2 Kinase inhibitors ALLERGAN, INC. (US) 2010-07-06 US disclosed
WO-2010075197-A1 KINASE INHIBITORS ALLERGAN, INC. (US) 2010-07-01 WO disclosed
US-7692005-B2 Kinase inhibitors ALLERGAN, INC. (US) 2010-04-06 US disclosed
US-20090208557-A1 Kinase inhibitors ALLERGAN, INC. 2009-08-20 US disclosed
EP-1902025-A1 KINASE INHIBITORS Allergan, Inc. (US) 2008-03-26 EP disclosed
US-20070032478-A1 Kinase Inhibitors ALLERGAN, INC. 2007-02-08 US disclosed
WO-2007008895-A1 KINASE INHIBITORS ALLERGAN, INC. (US) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090208557-A1 Kinase inhibitors PTK2, MAP3K6, MAP3K20 ALDH1A1 2605/4885CYP1A2 3931/4885CYP3A4 4156/4885
US-20070032478-A1 Kinase Inhibitors ABL1, LCK, ERBB2 ALDH1A1 2379/4885CYP1A2 4043/4885CYP3A4 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.